MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
2. Industry_Business Architects & Consolidators
Industry: By Region (Globally)
Industry: International
Industry: West + Pacific Rim
*Industry: Southern California
*Industry: Los Angeles, California
Puma Biotechnology, Inc (NASDAQ: PBYI)*
Organization & Developments: Puma
Parents
Puma Biotechnology, Inc (NASDAQ: PBYI)*
Children
*Company focused on the development and acquisition of cancer therapies
*Development-stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer.
*Our strategy is to license technologies that have previously been tested in clinical trials, enabling us to obtain an initial indication of the drug's safety and biological activity in humans before committing capital to the drug's development.
2011: Puma Biotechnology-Puma Biotechnology-Closes $55 Million Private Placement and Completes Merger (2011)
2018: Is This 'As Good As It Gets' For This Biotech's Breast Cancer Drug?www.investors.com
2018: Puma Biotech: Is It Time For This Kitty To Roar?
2018: Puma Biotechnology: Risky Investment - Puma Biotechnology, Inc. (NYSE:PBYI)
2020: Puma Biotechnology: Still Bullish At These Prices
2020: Puma Biotechnology: Waiting For Commercial Numbers To Catch Up To Clinical Data
2021: Puma Biotech Struggles To Find Its Footing In Crowded Oncology Space
2022: Puma Bio: Still Worthy Of Consideration After Earnings Surprise_seekingalpha.com
2022: Puma Biotechnology: Alisertib Deal Alters My Strategy_seekingalpha.com
2023: Puma Biotechnology: Profitable, Troubled, But Worth A Good Look_seekingalpha.com
2024: Puma Biotech Launches Phase 2 Trial for Advanced Breast Cancer Treatment
2024: Puma Biotechnology, Inc. 2023 Q4 - Results - Earnings Call Presentation
2024: Puma Biotechnology: Continuing To Push Their Aurora Kinase Story Forward
Jumps
*Key People: Puma
Finance & Acquisitions: Puma